Mucopolysaccharidosis type VI: Identification of novel mutations on the arylsulphatase B gene in South American patients

J Inherit Metab Dis. 2005;28(6):1027-34. doi: 10.1007/s10545-005-0020-2.

Abstract

Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome, MPS VI) is an autosomal recessive disorder caused by deficiency of N-acetylgalactosamine-4-sulphatase (ARSB),which leads to the lysosomal accumulation and excretion of dermatan sulphate (DS). In this study, 13 unrelated MPS VI patients (12 Brazilian and 1 Chilean) were investigated regarding the identification of the ARSB gene mutations using PCR, SSCP and sequencing. The exons with altered mobility on SSCP were sequenced, as well as all the exons of patients with no SSCP alteration. Seven novel mutations were identified: D59N, L72R, Q88H, P93S, R197X, 1279delA and c.1143-8T > G. The previously reported mutations 1533del23, R315Q and 427delG were found in six, three and two alleles respectively. The other mutations already reported, S384N and G144R, were found in only one allele. In addition, three polymorphisms previously described (V358M, V376M and P397P) were detected in the patients analysed. Our findings are in agreement with the literature confirming the great genetic heterogeneity associated with MPS VI.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Alleles
  • Child
  • Child, Preschool
  • Chondroitinsulfatases / genetics
  • DNA Mutational Analysis
  • Exons
  • Genetic Variation
  • Humans
  • Infant
  • Mucopolysaccharidosis VI / enzymology*
  • Mucopolysaccharidosis VI / genetics*
  • Mutation*
  • N-Acetylgalactosamine-4-Sulfatase / genetics*
  • Point Mutation
  • Polymerase Chain Reaction
  • Polymorphism, Genetic
  • Polymorphism, Single-Stranded Conformational
  • Sequence Analysis, DNA
  • South America

Substances

  • Chondroitinsulfatases
  • N-Acetylgalactosamine-4-Sulfatase